Sumitomo Chemical India Ltd (SUMICHEM) Q1 FY27 Results Analysis: PAT Grows 20%, Margin Expands 198 bps
Sumitomo Chemical India Ltd's Q1 FY27 numbers came in mixed, with revenue of Rs. 1,063.35 Cr (+0.62% YoY) and PAT growth of +20.46% YoY. Here's a quick read of what worked, what to watch, and what management said.
| Results date | July 27, 2026 |
|---|---|
| Quarter | Q1 FY 2026-2027 |
| Revenue (Q1) | Rs. 1,063.35 Cr (+0.62% YoY) |
| PAT (Q1) | Rs. 214.83 Cr (+20.46% YoY) |
| EBITDA margin | 26.39% (+198 bps YoY) |
| EPS (Q1) | Rs. 4.30 (+20.40% YoY) |
| Market cap | Rs. 26,082.85 Cr |
| CMP | Rs. 522.55 |
Quarter Snapshot
Revenue was flat YoY as delayed monsoon impacted kharif volumes, but EBITDA margin expanded 198 bps to 26.39%, beating the >20% target. PAT grew 20% YoY, partly due to an insurance claim. The raw material cost tailwind from the zero-duty window expires in Q2, posing a near-term margin risk.
Key Investment Insights
Key Positives
- EBITDA margin expanded 198 bps YoY to 26.39%, exceeding the company's >20% target.
- PAT attributable to owners grew 20.46% YoY to Rs.214.83 crore.
- Raw material cost ratio improved 112 bps YoY to 60.81% of revenue.
- Normalized PAT (excluding exceptional gain) grew ~9.23% YoY.
- Finance costs remain negligible at 0.19% of revenue, reflecting a debt-free balance sheet.
Risk Factors
- Revenue was nearly flat YoY (+0.62%) due to delayed monsoon and weak kharif sowing.
- The zero-duty import window on chemical inputs expired on 30 Jun 2026, removing the raw material cost tailwind for Q2.
- Subsidiaries contributed a net loss of Rs.1.70 crore to consolidated PAT.
Ask about this
Ask Cofacto a question about this result. Answers cite filings and company data.
Related
Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.